Researchers develop a safer carrier for cancer vaccines

Lipid nanoparticle (LNP)-based messenger ribonucleic acid (mRNA) vaccines have recently emerged as a promising strategy for the prevention and treatment of cancers, as well as infectious diseases. LNPs are carriers that safely ...

Tablet-based vaccine prevents urinary tract infections in mice

Biomedical engineers at Duke University have developed a tablet-based vaccine for urinary tract infections (UTIs) that rapidly dissolves when placed under the tongue. The new treatment could offer an easy and practical alternative ...

Efficient nanovaccine delivery system boosts cellular immunity

Cancer immunotherapies, such as immune checkpoint inhibition therapy, have been attracting attention in recent years as new methods for treating cancer. However, immune checkpoint inhibition therapy is only effective in 20%–30% ...

page 10 from 39